Watson 372 50 mg Pill - blue & white capsule/oblong, 19mm
Pill with imprint Watson 372 50 mg is Blue & White, Capsule/Oblong and has been identified as Loxapine Succinate 50 mg. It is supplied by Watson Laboratories, Inc.
Loxapine is used in the treatment of Agitation; Schizophrenia; Agitated State and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Watson 372 50 mg
Loxapine Succinate
- Imprint
- Watson 372 50 mg
- Strength
- 50 mg
- Color
- Blue & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antipsychotic agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
-
lactose anhydrous,
benzyl alcohol,
butylparaben,
edetate calcium disodium,
gelatin,
magnesium stearate,
methylparaben,
polacrilin potassium,
propylparaben,
sodium lauryl sulfate,
sodium propionate,
magnesium silicate,
titanium dioxide,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00591-0372 | Watson Pharmaceuticals, Inc. |
51079-0903 (Discontinued) | UDL Laboratories Inc. |
Related images for "Watson 372 50 mg"
More about loxapine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (22)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antipsychotic agents
- Breastfeeding
- En español
Patient resources
- Loxapine drug information
- Loxapine (Inhalation) (Advanced Reading)
- Loxapine (Oral) (Advanced Reading)
- Loxapine Capsules
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.